OBJECTIVE: To identify the incidence of obstructive sleep apnea (OSA) in patients treated for head and neck cancer. Obstructive sleep apnea is a relatively common and highly morbid condition that affects 9.1% of male and 4% of female middle-aged adults.1 Patients who have been successfully treated for head and neck cancer may often have a partially obstructed upper airway which is functional during the day, but collapses during sleep. STUDY DESIGN/ METHODS: Twenty-four patients successfully treated for tumors of the tongue-base, pharynx, or supraglottic larynx were enrolled. Through OSA-related questionnaires, physical examination, and polysomnography, the incidence of OSA in this patient population was determined and compared with that of the general population. RESULTS: The incidence of OSA (91.7%) in this head and neck cancer patient population was found to be significantly (P =.001) higher than that of the general population. (In a random sampling of middle-aged adult males between the ages of 30 and 60 years old with a respiratory disturbance index (RDI) >15, the prevalence was previously reported to be 9.1%.1) Sixteen of 24 patients (72.7%) had clinically defined symptoms of sleep apnea. Ten of 24 patients (41.7%) received radiation therapy; all had an RDI >15. Eleven of the 14 patients (78.5%) who did not receive radiation therapy also had an RDI >15. Eight patients (33.3%) continue to regularly use continuous positive airway pressure with significant improvement in symptoms. CONCLUSIONS: Identification and treatment of OSA may be an important factor in improving quality of life for patients with head and neck cancer.
OBJECTIVE: To identify the incidence of obstructive sleep apnea (OSA) in patients treated for head and neck cancer. Obstructive sleep apnea is a relatively common and highly morbid condition that affects 9.1% of male and 4% of female middle-aged adults.1 Patients who have been successfully treated for head and neck cancer may often have a partially obstructed upper airway which is functional during the day, but collapses during sleep. STUDY DESIGN/ METHODS: Twenty-four patients successfully treated for tumors of the tongue-base, pharynx, or supraglottic larynx were enrolled. Through OSA-related questionnaires, physical examination, and polysomnography, the incidence of OSA in this patient population was determined and compared with that of the general population. RESULTS: The incidence of OSA (91.7%) in this head and neck cancerpatient population was found to be significantly (P =.001) higher than that of the general population. (In a random sampling of middle-aged adult males between the ages of 30 and 60 years old with a respiratory disturbance index (RDI) >15, the prevalence was previously reported to be 9.1%.1) Sixteen of 24 patients (72.7%) had clinically defined symptoms of sleep apnea. Ten of 24 patients (41.7%) received radiation therapy; all had an RDI >15. Eleven of the 14 patients (78.5%) who did not receive radiation therapy also had an RDI >15. Eight patients (33.3%) continue to regularly use continuous positive airway pressure with significant improvement in symptoms. CONCLUSIONS: Identification and treatment of OSA may be an important factor in improving quality of life for patients with head and neck cancer.
Authors: Saadia A Faiz; Diwakar Balachandran; Amy C Hessel; Xiudong Lei; Beth M Beadle; William N William; Lara Bashoura Journal: Oncologist Date: 2014-10-01
Authors: Andrew G Shuman; Sonia A Duffy; David L Ronis; Susan L Garetz; Scott A McLean; Karen E Fowler; Jeffrey E Terrell Journal: Laryngoscope Date: 2010-06 Impact factor: 3.325
Authors: Bryce B Reeve; Jianwen Cai; Hongtao Zhang; Jaeun Choi; Mark C Weissler; David Cella; Andrew F Olshan Journal: Head Neck Date: 2012-08-21 Impact factor: 3.147
Authors: Sonia A Duffy; David L Ronis; Scott McLean; Karen E Fowler; Stephen B Gruber; Gregory T Wolf; Jeffrey E Terrell Journal: J Clin Oncol Date: 2009-03-16 Impact factor: 44.544
Authors: Sonia A Duffy; Theodoros Teknos; Jeremy M G Taylor; Karen E Fowler; Mozaffarul Islam; Gregory T Wolf; Scott McLean; Tamer A Ghanem; Jeffrey E Terrell Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-01-08 Impact factor: 4.254
Authors: Ronald Gavidia; Galit Levi Dunietz; Louise O'Brien; Carol Shannon; Sonja Schuetz; Matthew Spector; Paul Swiecicki; Ronald D Chervin Journal: J Clin Sleep Med Date: 2021-05-01 Impact factor: 4.062